These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18772850)

  • 1. [The biological role of D-glucaric acid and its derivatives: potential use in medicine].
    Zółtaszek R; Hanausek M; Kiliańska ZM; Walaszek Z
    Postepy Hig Med Dosw (Online); 2008 Sep; 62():451-62. PubMed ID: 18772850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism, uptake, and excretion of a D-glucaric acid salt and its potential use in cancer prevention.
    Walaszek Z; Szemraj J; Narog M; Adams AK; Kilgore J; Sherman U; Hanausek M
    Cancer Detect Prev; 1997; 21(2):178-90. PubMed ID: 9101079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-glucaro-1,4-lactone: its excretion in the bile and urine and effect on the biliary secretion of beta-glucuronidase after oral administration in rats.
    Macfadyen A; Ho KJ
    Hepatology; 1989 Apr; 9(4):552-6. PubMed ID: 2925160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential use of D-glucaric acid derivatives in cancer prevention.
    Walaszek Z
    Cancer Lett; 1990 Oct; 54(1-2):1-8. PubMed ID: 2208084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-D-glucarate.
    Altern Med Rev; 2002 Aug; 7(4):336-9. PubMed ID: 12197785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of gastrointestinal beta-glucuronidase by polyvinylbenzyl D-glucaro(1,4)lactonate: attachment of D-glucaro(1,4)lactone to polyvinylbenzyl chloride.
    Sacco C; McEwen WE; Calabrese EJ
    Hum Exp Toxicol; 1993 Mar; 12(2):181-4. PubMed ID: 8096720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugation-deconjugation cycling of diflunisal via beta-glucuronidase catalyzed hydrolysis of its acyl glucuronide in the rat.
    Brunelle FM; Verbeeck RK
    Life Sci; 1997; 60(22):2013-21. PubMed ID: 9180355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis of D-glucaric acid in mammals: a free-radical mechanism?
    Marsh CA
    Carbohydr Res; 1986 Sep; 153(1):119-31. PubMed ID: 3779687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of gastrointestinal beta-glucuronidase by poly(vinylbenzyl D-glucaro(1,4)lactonate). Part 2. Poly(vinylbenzyl D-glucaro(1,4) lactonate) in vitro inhibition studies.
    Sacco C; Calabrese EJ
    Hum Exp Toxicol; 1994 Nov; 13(11):759-63. PubMed ID: 7857695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hepatic beta-glucuronidase: an enzyme kinetic study.
    Ho YC; Ho LH; Ho KJ
    Enzyme; 1985; 33(1):9-17. PubMed ID: 3987656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calcium glucarate on beta-glucuronidase activity and glucarate content of certain vegetables and fruits.
    Dwivedi C; Heck WJ; Downie AA; Larroya S; Webb TE
    Biochem Med Metab Biol; 1990 Apr; 43(2):83-92. PubMed ID: 2346674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detoxifying cancer causing agents to prevent cancer.
    Hanausek M; Walaszek Z; Slaga TJ
    Integr Cancer Ther; 2003 Jun; 2(2):139-44. PubMed ID: 15035900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of D-glucuronolactone in mammalian systems. Inhibitory properties of the products of D-glucuronolactone-dehydrogenase action.
    Marsh CA
    Biochem J; 1966 Apr; 99(1):22-7. PubMed ID: 5965340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary glucarate as anti-promoter of 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis.
    Walaszek Z; Hanausek-Walaszek M; Minton JP; Webb TE
    Carcinogenesis; 1986 Sep; 7(9):1463-6. PubMed ID: 3091283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumorigenesis by 2,5-di-O-acetyl-D-glucaro-1,4:6,3-dilactone, an in vivo beta-glucuronidase inhibitor.
    Walaszek Z; Hanausek-Walaszek M; Webb TE
    Carcinogenesis; 1984 Jun; 5(6):767-72. PubMed ID: 6202433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary D-glucaric acid: its quantitation and preventive role in gallstone formation.
    Ho YD; Ho KJ
    Scand J Gastroenterol; 1990 Jun; 25(6):631-40. PubMed ID: 2359994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of urinary beta-glucuronidase activity. Single-point versus enzyme kinetic measuring system.
    Ho KJ; Ho LH
    Enzyme; 1980; 25(6):361-70. PubMed ID: 7202386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of biomarkers related to tumor initiation and promotion in mouse skin by a natural β-glucuronidase inhibitor and its precursors.
    Kowalczyk MC; Spears E; Narog M; Zoltaszek R; Kowalczyk P; Hanausek M; Yoshimi N; Slaga TJ; Walaszek Z
    Oncol Rep; 2011 Sep; 26(3):551-6. PubMed ID: 21687956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different inhibition rates of beta-glucuronidase fractions in human gallbladder bile by glucaro-1, 4-lactone.
    Masuda H; Heirwegh KP
    Fukuoka Igaku Zasshi; 1979 Sep; 70(9):529-32. PubMed ID: 511089
    [No Abstract]   [Full Text] [Related]  

  • 20. Repression by sustained-release beta-glucuronidase inhibitors of chemical carcinogen-mediated induction of a marker oncofetal protein in rodents.
    Walaszek Z; Hanausek-Walaszek M; Webb TE
    J Toxicol Environ Health; 1988; 23(1):15-27. PubMed ID: 3336058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.